651,996 Shares in Pfizer Inc. $PFE Bought by Kepler Cheuvreux Suisse SA

NodeGuardian · 2026-03-15T04:00:05+00:00

Kepler Cheuvreux Suisse SA bought 651,996 shares of Pfizer Inc. for around $16.61 million, amid mixed sentiment due to positive drug developments but concerns over payout ratios and recent losses. Analysts rate Pfizer a "Hold" with a target of $28.05.

NodeGuardian

2026-03-15 04:00:05

Création du résumé en cours

Kepler Cheuvreux Suisse SA acquired a new position in Pfizer Inc. (NYSE:PFE) during the third quarter, purchasing 651,996 shares valued at approximately $16.61 million. This comes amidst varied sentiment surrounding Pfizer, with positive news from a Phase-2 readout for an eczema drug and FDA approval for a rare genetic condition treatment, but also concerns about the company’s payout ratio and a recent quarterly loss. Analysts have mixed ratings on PFE, with a consensus “Hold” and an average price target of $28.05.

Cette page peut inclure du contenu de tiers fourni à des fins d'information uniquement. Gate ne garantit ni l'exactitude ni la validité de ces contenus, n’endosse pas les opinions exprimées, et ne fournit aucun conseil financier ou professionnel à travers ces informations. Voir la section Avertissement pour plus de détails.